Prostate cancer decisions — 2024

The Board has dismissed the Veteran's claims for service connection for right and left knee degenerative arthritis, as these conditions are considered manifestations of previously service-connected disabilities. The appeals for type two diabetes mellitus, prostate cancer, urinary incontinence secondary to prostate cancer, and erectile dysfunction secondary to prostate cancer or post-operative residuals of left knee Osgood-Schlatter's disease have been remanded due to the need for additional development regarding possible exposure to herbicide agents.

The Board has denied the Veteran's claim for service connection for coronary artery disease, and has remanded the claims for service connection for prostate cancer and metastatic bone cancer associated with primary prostate cancer.

The Board has remanded the Veteran's claims for service connection due to his exposure to carbon tetrachloride and ionizing radiation during service. Additional development is needed, including obtaining medical opinions on whether these exposures caused or contributed to the Veteran's claimed conditions.

The Board granted service connection for a heart condition, hypertension, bilateral lower extremity peripheral neuropathy, and an acquired psychiatric disorder as secondary to the Veteran's service-connected prostate cancer. The claim for a compensable disability rating for erectile dysfunction was withdrawn by the Veteran, and the discontinuance of the 100 percent rating for residuals of prostate cancer was deemed proper.

The Veteran's prostate cancer rating was reduced from 100 percent to 60 percent, and the claim for an increased rating is denied.,ED has been dismissed as the Veteran did not timely appeal the March 2021 decision granting service connection for ED with a non-compensable rating.,The Veteran's bilateral hearing loss claim is remanded due to inadequate medical opinion regarding its etiology.

The Board is remanding the case to determine if the Veteran's prostate cancer is related to his exposure to herbicides while stationed in Korea.

The Veteran's claims for service connection for diabetes mellitus, type II and prostate cancer were granted with an effective date of March 25, 2014. The rating assigned was 10% for each condition as of July 12, 2022.

The Veteran's claims for service connection are remanded due to the need for additional development, including obtaining records from SSA and VA Community Care Network, verifying TERA exposure, and conducting examinations related to his claimed conditions.

The Veteran's cause of death was attributed to prostate cancer, which the Board found not service-connected. The claim for DIC under 38 U.S.C. § 1318 was also denied as the Veteran did not meet the criteria for a total disability rating based on individual unemployability.

The Veteran's claims for increased ratings and service connection have been denied. The Board found that the evidence did not meet the criteria for a higher rating or service connection in all cases.

The Board has granted service connection for tinnitus, but has remanded the issues of service connection for ischemic heart disease, prostate cancer, hypertension, diabetes mellitus type II, and diabetic peripheral neuropathy due to incomplete service records and lack of verification of herbicide agent exposure.

The Board denied service connection for prostate cancer, malignant carcinoid of the small intestine, and metastatic carcinoid of the liver. The cancers are presumed to be related to contaminated water exposure at Camp Lejeune during active duty.

The Veteran's claim for prostate cancer was granted on a direct basis due to the PACT Act, and an effective date of August 10, 2022, is assigned. The Board denied an earlier effective date as the evidence did not support such.

Service connection is granted for hypertension and prostate cancer, both on a presumptive basis due to service in Vietnam. Service connection for PTSD is also granted.,The Veteran's bilateral foot disability is remanded as the current opinion does not address overuse syndrome. The claim for service connection for an eye disability secondary to hypertension is also remanded.

The Veteran's claim for a rating in excess of 20 percent for prostate cancer residuals, including the issue of whether the reduction from 100 percent to 20 percent was proper, is being remanded due to incomplete records and conflicting medical findings.

The Board has granted service connection for prostate cancer, finding that the Veteran's duties placed him near U-Tapao Royal Thai Air Force Base in Thailand where he is presumed to have been exposed to herbicide agents. The effective date of this decision is not specified.

The Board has determined that the Veteran's ischemic heart disease and prostate cancer, which are presumed service-connected due to herbicide exposure, contributed substantially or materially to his cause of death. The benefit sought is granted.

The Veteran's claim for service connection of prostate cancer is granted. A separate compensable rating for insomnia due to tinnitus is also granted. The Veteran's request for an increased rating for his tinnitus, which is already at the maximum schedular rating, is denied.

The appeal to reduce the rating for prostate cancer residuals from 100 percent to noncompensable is dismissed because it was a proposal and not a final decision.

The Veteran's service-connected disabilities resulted in a need for regular aid and attendance from February 5, 2007, to October 13, 2020, resulting in the grant of SMC A&A.,For the entire appeal period, the Veteran was assigned the maximum schedular rating (100%) for prostate cancer due to service-connected conditions and is therefore denied an increased rating.,The Veteran's metastatic disease of the pelvis, spine, and proximal femur also received a maximum schedular rating (100%) throughout the appeal period, precluding any increase in disability ratings.,Diabetes mellitus, type II, was rated at 20% for the entire appeal period. The Veteran is denied an increased rating as there are no additional criteria met to warrant a higher rating.